Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Scott Solomon and Orly Vardeny.
Scott Solomon
Connection Strength
5.298
Orly Vardeny
  1. Applying the Lessons of Influenza to COVID-19 During a Time of Uncertainty. Circulation. 2020 May 26; 141(21):1667-1669.
    View in: PubMed
    Score: 0.874
  2. High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial. Am Heart J. 2018 08; 202:97-103.
    View in: PubMed
    Score: 0.769
  3. Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circ Heart Fail. 2018 04; 11(4):e004745.
    View in: PubMed
    Score: 0.761
  4. Influenza vaccination: a one-shot deal to reduce cardiovascular events. Eur Heart J. 2017 02 01; 38(5):334-337.
    View in: PubMed
    Score: 0.703
  5. Influenza vaccination: a 'shot' at INVESTing in cardiovascular health. Eur Heart J. 2021 05 21; 42(20):2015-2018.
    View in: PubMed
    Score: 0.237
  6. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021 May 01; 181(5):714-717.
    View in: PubMed
    Score: 0.236
  7. Complications in Patients With COVID-19-Reply. JAMA Cardiol. 2021 03 01; 6(3):360.
    View in: PubMed
    Score: 0.233
  8. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021 01; 9(1):65-73.
    View in: PubMed
    Score: 0.230
  9. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 07 01; 5(7):831-840.
    View in: PubMed
    Score: 0.223
  10. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 04 23; 382(17):1653-1659.
    View in: PubMed
    Score: 0.219
  11. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiol. 2018 03 01; 3(3):200-206.
    View in: PubMed
    Score: 0.189
  12. An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality. J Am Heart Assoc. 2017 Mar 24; 6(4).
    View in: PubMed
    Score: 0.177
  13. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2016 Oct; 18(10):1228-1234.
    View in: PubMed
    Score: 0.168
  14. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail. 2022 01; 28(1):93-112.
    View in: PubMed
    Score: 0.060
  15. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020 12 18; 18(1):403.
    View in: PubMed
    Score: 0.057
  16. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 11 17; 76(20):2368-2378.
    View in: PubMed
    Score: 0.057
  17. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 10 13; 76(15):1777-1794.
    View in: PubMed
    Score: 0.057
  18. Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. JACC Heart Fail. 2018 10; 6(10):844-855.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.